Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998

被引:127
作者
Ferro, JM [1 ]
Correia, M [1 ]
Pontes, C [1 ]
Baptista, MV [1 ]
Pita, F [1 ]
机构
[1] Hosp Santa Maria, Ctr Estudos Egas Moinz, Dept Neurol, P-1649035 Lisbon, Portugal
关键词
cerebral vein; dural sinus; thrombosis; anticoagulation; prognosis;
D O I
10.1159/000047635
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is insufficient information on the prognosis and safety of anticoagulation in acute cerebral vein and dural sinus thrombosis (CVDST). To describe the clinical aspects and medical management of CVDST in Portuguese hospitals, to evaluate the safety of anticoagulation in this setting, and to identify subgroups of CVDST patients with different prognoses, we registered symptomatic CVDST patients admitted to Portuguese hospitals since 1980, Cases were collected from file review up to 6/95 and from consecutively admitted patients from 6/95 to 6/98, One hundred and forty-two patients were included from 20 centers (51 retrospectively and 91 prospectively). One hundred and twelve patients (79%) were anticoagulated. There were only 6 new intracranial hemorrhages (4 in anticoagulated patients) and 2 systemic hemorrhages, Nine (6%) patients died. At discharge, 96 [68%), had recovered completely and only 6 (4%) were dependent (Rankin greater than or equal to 3). Significant multivariate predictors of death/dependency were central nervous system infection as a predisposing cause (odds ratio, OR = 15.4; 95% confidence interval Cl = 111-1.1), encephalopathy on admission (OR = 5.2; 95% Cl = 18.7-1.5) and hemorrhage on admission CT/MR (OR = 3.6; 95% Cl = 12.9-1). Significant predictors of complete recovery were no encephalopathy on admission (OR = 5; 95% Cl = 12.5-2.1), age <45 years (OR = 3.8; 95% Cl = 9.2-1.6) and anticoagulation (OR = 3.8; 95% Cl = 9.6-1.5). It is possible to identify CVDST patients with potential bad or good prognosis in the acute phase. Anticoagulation was safe and a predictor of complete recovery in acute CVDST, Copyright <(c)> 2001 S. KargerAG, Basel.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 27 条
[1]  
[Anonymous], 1967, CLIN NEUROSURG
[2]  
Barinagarrementeria F, 1992, J Stroke Cerebrovasc Dis, V2, P34, DOI 10.1016/S1052-3057(10)80032-1
[3]  
BENHAMOUDAMRAD I, 1995, REV NEUROL-FRANCE, V151, P563
[4]   Frequency of the 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis [J].
Biousse, V ;
Conard, J ;
Brouzes, C ;
Horellou, MH ;
Ameri, A ;
Bousser, MG .
STROKE, 1998, 29 (07) :1398-1400
[5]   Isolated intracranial hypertension as the only sign of cerebral venous thrombosis [J].
Biousse, V ;
Ameri, A ;
Bousser, MG .
NEUROLOGY, 1999, 53 (07) :1537-1542
[6]   CEREBRAL VENOUS THROMBOSIS - A REVIEW OF 38 CASES [J].
BOUSSER, MG ;
CHIRAS, J ;
BORIES, J ;
CASTAIGNE, P .
STROKE, 1985, 16 (02) :199-213
[7]   Cerebral venous thrombosis - Nothing, heparin, or local thrombolysis? [J].
Bousser, MG .
STROKE, 1999, 30 (03) :481-483
[8]  
Bousser MG., 1997, Major problems in neurology, P27
[9]  
BOUSSER MG, 1997, MAJOR PROBLEMS NEURO, V33, P104
[10]  
BOUSSER MG, 1999, CURRENT REV CEREBROV, P109